Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Egalet Corp (EGLTQ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Egalet historical data, for real-time data please try another search
0.01 0.00    0.00%
01/02 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 0.01 - 0.01
Egalet 0.01 0.00 0.00%

EGLTQ User Rankings

 
Users ranking according to the performance of their sentiments for the Egalet Corp stock.
RankUsernameTotalClosedWinningWin %Chg. %
1مهند العقيد33266.67+55200%
2هانى العقيد44250+55200%
3Alberto Previati66466.67+30829.3%
4RGLD111100+27600%
5AMATO PETITO111100+27600%
6تلاتلا تلاهىهن222100+11341.7%
7Daniele De Pace22150+703.98%
8Rambabu Verma111100+58.82%
9Alex Joseph111100+33.67%
10Francesco Deluca111100+31.38%
11davide garulli55360+28.2%
12ryan riemensnider111100+23.68%
13Miguel Clos Uribe111100+17.03%
14Sonia Marti111100+12.09%
15Valdek Kazana111100+4.2%
16gwilym Phillips111100+4.05%
17Shimon Zhitar111100+1.32%
18OI EI1100-1.32%
19Marko Lillemets1100-2.28%
20Johnny Li1100-2.7%
21Errol Rackipov1100-2.86%
22M G1100-3.75%
23LukeDandy1100-9.3%
24Юрий Болдырев1100-12.61%
25Carlos Heredia Moya1100-15.74%
26Silvy C.1100-16.43%
27valerij andrijchuk1100-18.92%
28Will Engelman1100-22.39%
29Olga Mirasol Hernandez22150-22.92%
30Chance Gustafson1100-30.18%
31Frédéric Brisson1100-31.38%
32Estefania Juste1100-31.38%
33Shannon Milller1100-33.67%
34Raffy Guda1100-33.67%
35Andrea Mango1100-33.67%
36Evens Balthazar1100-61.11%
37bo ma1100-739.39%
38Tage Tagenet2200-1770.13%
39JF ISSENMANN1100-1878.57%
40Luca Alabam1100-2670%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

EGLTQ Comments

Write your thoughts about Egalet Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
David Alexander Peterson
David Alexander Peterson Oct 09, 2016 8:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Egalet (NASDAQ: EGLT) came public in 2014 and has a market capitalization of just $200 million at the moment. Its primary drug candidate is an abuse resistant pain compound called ARYMO ER that has an October 14th PDUFA date. Approval is highly likely as ARYMO ER was recommended for approval in early August by its Ad Comm panel by an 18 to 1 vote. The shares could also be helped this week as Pain Therapeutics’ (NASDAQ: PTIE) application for pain management drug Remoxy ER was rejected by the FDA which cratered its stock and might have investors looking for alternatives in the space. The stock of Egalet sells for just under $8 a share currently. Cantor Fitzgerald reiterated a Buy rating and $21 price target on the shares earlier in September.
Oct 09, 2016 8:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1.60 on july6
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email